Section 21. Result Management process.

1[21. Result Management process.---(1) After receiving an adverse report from a dope testing laboratory indicating presence of any prohibited substance or its metabolites or markers in the sample of an athlete or evidence of the use of a prohibited method, the Agency shall carry out initial examination of the report in such manner as may be specified by regulations and verify, if Therapeutic Use Exemption has been granted to such athlete in respect of such substance or if there has been any departure from the International Standard for Laboratories or International Standard for Testing and Investigations that may have caused the adverse analytical finding or if it is apparent that the adverse analytical finding was caused by an ingestion of the relevant prohibited substance through a permitted route. (2) Where, after examination and verification under sub-section (1), the Agency is satisfied that no Therapeutic Use Exemption has been granted to the athlete and that there has been no departure from the International Standard for Laboratories or International Standard for Testing and Investigations that may have caused the adverse analytical finding or that the adverse analytical finding was not caused by an ingestion of the relevant prohibited substance through a permitted route, it shall take such actions in such manner, as may be specified by regulations.]